Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aluminum salts, commonly used as vaccine adjuvants, activate the immune system through the depot effect. This involves retaining antigens at the injection site for prolonged exposure to immune cells, leading to enhanced antigen uptake by macrophages and dendritic cells. The aluminum salts activate the NLRP3 inflammasome, triggering the release of pro-inflammatory cytokines like IL-1β and IL-18, and promoting a Th2-type immune response. While effective in enhancing antibody production, potential safety concerns include injection site reactions and localized inflammation.
Antigen retention at injection site, NLRP3 inflammasome activation, and induction of Th2-biased immune response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System Activation via Depot Effect (Aluminum Salt).